Skip to content

Regeneration of Intrabony Defects With Nano Hydroxyapatite Graft, and Periosteum as Barrier Membrane Under Magnification

Regeneration of Intrabony Defects With Nano Hydroxyapatite Graft, Derived From Egg Shell Along With Periosteum as Barrier Membrane Under Magnification - An Interventional Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04195295
Enrollment
30
Registered
2019-12-11
Start date
2019-12-12
Completion date
2021-11-30
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrabony Periodontal Defect

Brief summary

The prospective study is a interventional study to evaluate and compare the effectiveness of periosteal pedicle as grafting technique and egg shell derived nano hydroxyapatite as regenerative graft material for regeneration of intrabony defects.

Detailed description

30 Patients visiting the outpatient Department of Periodontology Krishnadevaraya College of Dental Sciences and Hospital, Bangalore will be enrolled for 6 month folllow up study based on the inclusion and exclusion criteria. Patients age ranged from 25 to 55 years. Patients with chronic periodontitis, with presence of intrabony defects with ≥6mm probing depth (PD), 2 or 3 wall defects are included in the study. The patients are allocated to three goups through computer generated randomisation as: Group A (n=10) - Egg shell derived nano hydroxyapatite (EnHA) graft and periosteal pedicle as barrier membrane. Group B (n=10) - Only EnHA as graft. Group C (n=10) - An open flap debridement procedure only.

Interventions

PROCEDURERegeneration of Intrabony Defects with Nano Hydroxyapatite Graft, Derived from Egg Shell along with Periosteum as Barrier Membrane

* In group A, the full thickness mucoperiosteal flap will be elevated, which will be extended apically to expose sufficient amount of periosteum. * Periosteal membrane will be separated from the full thickness mucoperiosteal flap and released by one vertical incision mesially and one horizontal incision apically. * Posteriorly, the periosteum remained attached with the mucoperiosteal flap, so that blood supply could be maintained in the reflected periosteum. * Then the graft material will be packed into the defect. * Then periosteal membrane will be turned over the intrabony defect in such a way that the defect was completely covered by the periosteal membrane

PROCEDURERegeneration of intrabony defects using Egg shell derived nano hydroxyapatite (EnHA) as regenerative graft material

Full thickness mucoperiosteal flap will be raised and Vertical releasing incisions are used if necessary for better access to the surgical site. Then EnHA graft material will be placed into the defect before suturing the mucoperiosteal flap.

PROCEDUREOpen flap debridement procedure in intrabony defects.

full thickness mucoperiosteal flap will be raised, entire granulation tissue will be removed from the defects, the pocket epithelium was curetted from the inner surface of the flap, and the roots were thoroughly scaled and planed by means of manual and ultrasonic instruments. Then the operative area will be irrigated with sterile saline. After that, the mucoperiosteal flaps will be sutured.

Sponsors

Krishnadevaraya College of Dental Sciences & Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients within the age group of 25 to 55 years. 2. Patients with chronic periodontitis, with presence of intrabony defects with ≥6mm probing depth (PD), 2 or 3 wall defects as detected on CBCT. 3. Gingival biotype \>1.5mm 4. Systemically healthy subjects. 5. Patients who are compliant. 6. Patients who had not received any periodontal treatment in the last six months.

Exclusion criteria

1. Pregnant and Lactating females. 2. Aggressive periodontitis. 3. Presence of pulpal or periapical involvement. 4. Patients with known systemic diseases and conditions precluding any elective surgery. 5. Patients who were smokers. 6. Teeth with poor prognosis.

Design outcomes

Primary

MeasureTime frameDescription
Bone defect fill and density6 monthsbone defect fill and bone density will be measured pre operatively and post operatively using CBCT

Secondary

MeasureTime frameDescription
Probing pocket depth6 monthsprobing pocket depth is measured using UNC 15 probe pre operatively and post operatively

Countries

India

Contacts

Primary ContactDr. Rashmi P, MDS
rashprams2005@yahoo.co.in9900925844
Backup ContactDr. Sri Vani T. M, MDS
vani.tammina@gmail.com9406443033

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026